SCHEMBL4798458

SCHEMBL4798458

CC(C)N(C(=O)c1ccc(C(F)(F)F)cc1C(F)(F)F)c1ccc[c]c1-c1cc2ncccn2n1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
CES2 O00748 1/20 0.33
GPBAR1 Q8TDU6 1/20 0.33
POLQ O75417 3/20 0.32
TRPV4 Q9HBA0 1/20 0.32
HDAC8 Q9BY41 2/20 0.32
CYP2C9 P11712 6/20 0.32
CYP2B6 P20813 6/20 0.32
CYP2C19 P33261 5/20 0.32
CYP2C8 P10632 5/20 0.32
CYP2D6 P10635 4/20 0.32
CYP1A2 P05177 2/20 0.32
AVPR2 P30518 1/20 0.32
GPR27 Q9NS67 1/20 0.32
CYP3A4 P08684 1/20 0.32
ABL1 P00519 1/20 0.31
BCR P11274 1/20 0.31
PDGFRB P09619 2/20 0.31
KDR P35968 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4731314 0.80 APOBEC3A (0.33) APOBEC3AAPOBEC3GPOLQCYP2C9CYP2B6
SCHEMBL4731297 0.78 TP53 (0.34) CYP2C9CYP2B6CYP2C19CYP2C8CYP2D6
SCHEMBL4732780 0.73 NTRK1 (0.34) APOBEC3AAPOBEC3GABL1BCR
SCHEMBL4731374 0.71 NTRK1 (0.34)
SCHEMBL5310626 0.67 ALKBH5 (0.36) APOBEC3AAPOBEC3G
SCHEMBL5372491 0.64 NPSR1 (0.39) CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL5372495 0.64 GRM5 (0.37) APOBEC3AAPOBEC3GABL1BCRKIT
SCHEMBL4731299 0.63 APOBEC3A (0.35) APOBEC3AAPOBEC3GABL1KDRFGFR1
SCHEMBL1348539 0.62 KDM4E (0.49) APOBEC3AAPOBEC3GCYP1A2CYP3A4BRAF
SCHEMBL4732771 0.62 APOBEC3A (0.34) APOBEC3AAPOBEC3GCYP2C9CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008043791-A2 THIOPHENE DERIVATIVES FOR TREATING HEPATITIS C SMITHKLINE BEECHAM CORPORATION (US) 2008-04-17 WO disclosed